Government of Congo

Government

Also known as: INRB | Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo | Institut National de Research Biomédicale | Programme National de Lutte contre l'Onchocercose, Republic of the Congo

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 28, 2015

Last known activity

Jan 15, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (13 distinct, 10 trials)

Phase 4 (7 own, 0 via acquisition)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

tecovirimat

Other trials (1 own, 0 via acquisition)

ANSUVIMAB

Indications

Studied for

Malaria

Recent trials (12)

NCT05067166CollaboratorN/A—
NCT05067166Overall official - principal investigatorN/A—
NCT06613997Lead sponsorPhase 3Jan 15, 2025
NCT06289647CollaboratorPhase 4Jul 28, 2024
NCT06252961Lead sponsorPhase 2/Phase 3Jun 21, 2024
NCT06356974CollaboratorPhase 3Apr 8, 2024
NCT05734508CollaboratorPhase 4Mar 23, 2023
NCT05559099CollaboratorPhase 2Oct 10, 2022
NCT05119426CollaboratorPhase 4Jan 31, 2022
NCT05119426Overall official - principal investigatorPhase 4Jan 31, 2022
NCT04618523CollaboratorPhase 4Oct 26, 2020
NCT02342171CollaboratorPhase 2/Phase 3Feb 28, 2015

Details

Last known activity: Jan 15, 2025